anti-HBV infection program (Kagoshima University/ Oncolys)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nameanti-HBV infection program (Kagoshima University/ Oncolys)
Drug Alias Nameneplanocin A derivatives (Kagoshima University)AR-II-04-26MK-III-02-03
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKagoshima University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKagoshima UniversityOncolys Biopharma Inc
Active IndicationsN/A
Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A